Financial Perspectives’s VanEck Biotech ETF BBH Stock Holding History
Bought
Maintained
Sold
Other funds holding BBH
MIM
CCA
BFG
Financial Perspectives's BBH Position: Q1 2026 in Review
Financial Perspectives held its VanEck Biotech ETF (BBH) position steady in Q1 2026 at 88 shares worth $16.5K. The position accounts for ﹤0.01% of the portfolio, ranked #471.
Financial Perspectives first reported a position in BBH in Q4 2019 and has held it in 26 quarters since. The position peaked at $88K in Q1 2021. 112 funds tracked by Wall St. Rank hold BBH as of Q1 2026.
- Financial Perspectives held 88 shares of VanEck Biotech ETF worth $16.5K as of Q1 2026.
- Financial Perspectives left its VanEck Biotech ETF share count unchanged in Q1 2026.
- VanEck Biotech ETF made up ﹤0.01% of Financial Perspectives's portfolio in Q1 2026, its #471 holding.
- Financial Perspectives first reported a position in VanEck Biotech ETF in Q4 2019 and has held it in 26 quarters since.
- Financial Perspectives's VanEck Biotech ETF position peaked at $88K in Q1 2021.
- 112 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2026.
Based on Financial Perspectives's 13F filing for Q1 2026, filed 11 May 2026.